SCHEMBL23799162

SCHEMBL23799162

COc1ccc2c(c1)C1(CCC(N3CCCN(C)CC3)CC1)C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.42
SIGMAR1 Q99720 2/20 0.41
PDE7A Q13946 1/20 0.41
NPC1 O15118 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
AKR1B1 P15121 1/20 0.39
AURKB Q96GD4 4/20 0.39
PLK4 O00444 2/20 0.39
KDR P35968 1/20 0.39
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
OTUD7B Q6GQQ9 1/20 0.39
GHSR Q92847 1/20 0.38
ALDH1A1 P00352 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23799149 0.92 MAOA (0.41) FLT3SIGMAR1PDE7ANPC1TDP1
SCHEMBL23799175 0.90 PDE7A (0.47) FLT3SIGMAR1PDE7ANPC1TDP1
SCHEMBL23778269 0.86 HRH3 (0.42) FLT3PDE7AALDH1A1HRH3
SCHEMBL23798666 0.86 CYP1A2 (0.39) AKR1B1ALDH1A1OPRM1OPRK1OPRL1
SCHEMBL30179229 0.83 ALDH1A1 (0.47) ALDH1A1HRH3
SCHEMBL20066053 0.83 ALDH1A1 (0.47) ALDH1A1HRH3
SCHEMBL23798701 0.82 OPRM1 (0.51) OPRM1OPRK1OPRL1HTR7
SCHEMBL8320710 0.82 AKR1B1 (0.49) FLT3PDE7AAKR1B1AURKBPLK4
SCHEMBL23798608 0.82 ACVR1 (0.35) MAOAMAOBOTUD7B
SCHEMBL23797993 0.78 OPRL1 (0.37) OPRM1OPRK1OPRL1HRH3HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed